Comera Life Sciences Holdings, Inc. (CMRA): Price and Financial Metrics Recent IPO


Comera Life Sciences Holdings, Inc. (CMRA): $2.77

-0.14 (-4.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CMRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

CMRA Stock Price Chart Interactive Chart >

Price chart for CMRA

CMRA Price/Volume Stats

Current price $2.77 52-week high $11.44
Prev. close $2.91 52-week low $1.11
Day low $2.72 Volume 2,301,478
Day high $3.75 Avg. volume 4,427,405
50-day MA $2.60 Dividend yield N/A
200-day MA $0.00 Market Cap 36.68M

Comera Life Sciences Holdings, Inc. (CMRA) Company Bio


Comera Life Sciences Holdings, Inc. operates as a pre-clinical biotechnology company. It develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. The company's SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. Its products pipeline include CLS-001, an SQ formulation of a marketed, IV administered monoclonal antibody therapeutic for Crohn's disease and ulcerative colitis; CLS-002, an SQ formulation of a marketed, IV-administered immuno-oncology targeted monoclonal antibody for various oncology indications. The company was founded in 2014 and is based in Woburn, Massachusetts.


CMRA Latest News Stream


Event/Time News Detail
Loading, please wait...

CMRA Latest Social Stream


Loading social stream, please wait...

View Full CMRA Social Stream

CMRA Price Returns

1-mo 5.73%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3858 seconds.